Gene therapy for treating haemophilia: working to correct the body’s blood clotting “software”

28-Apr-2010 - Belgium

VIB and Cellectis, announced that they are going to collaborate on research into new approaches to cure haemophilia. Thierry Vandendriessche and Marinee Chuah from the VIB Vesalius Research Center at Katholieke Universiteit Leuven are going to use meganucleases – tailor made enzymes engineered by Cellectis - to replace faulty blood clotting factor genes with functional copies.

Genetic therapy has long been considered a rational approach to cure haemophilia. However, one of the major setbacks to date was that new genetic material was inserted anywhere into the DNA, possibly disrupting useful genes, leading to unwanted side effects or the lack of expression of the gene of interest. Cellectis’ meganuclease technology enables accurate insertion of functional copies of the FVIII and FIX genes in a way that does not disturb the other functions of the targeted cell.

“Meganucleases have the potential to solve the random insertion issue,” commented Vandendriessche and Chuah from the VIB Vesalius Research Center at K.U. Leuven. “The technique allows the new genes to be delivered at a predetermined and safe location, with great precision. We have high hopes that one day, this research will lead to life-enhancing therapies for haemophiliacs.”

Gene therapy can be compared to reprogramming a cell’s software by uploading a corrective patch. The genetic code is the programming language, the mutated gene is the bug in the software and the meganucleases are the patch.

Other news from the department science

These products might interest you

Limsophy

Limsophy by AAC Infotray

Optimise your laboratory processes with Limsophy LIMS

Seamless integration and process optimisation in laboratory data management

laboratory information management systems
ERP-Software GUS-OS Suite

ERP-Software GUS-OS Suite by GUS

Holistic ERP solution for companies in the process industry

Integrate all departments for seamless collaboration

software
Loading...

More news from our other portals

So close that even
molecules turn red...

See the theme worlds for related content

Topic world Gene therapy

Genetic diseases once considered untreatable are now at the center of innovative therapeutic approaches. Research and development of gene therapies in biotech and pharma aim to directly correct or replace defective or missing genes to combat disease at the molecular level. This revolutionary approach promises not only to treat symptoms, but to eliminate the cause of the disease itself.

View topic world
Topic world Gene therapy

Topic world Gene therapy

Genetic diseases once considered untreatable are now at the center of innovative therapeutic approaches. Research and development of gene therapies in biotech and pharma aim to directly correct or replace defective or missing genes to combat disease at the molecular level. This revolutionary approach promises not only to treat symptoms, but to eliminate the cause of the disease itself.